At HIMSS last week, Samsung announced a partnership with Travelers Insurance, Cedars-Sinai Medical Center, Bayer, and AppliedVR around using virtual reality for pain management. Samsung and Travelers will fund a 16-month study of between 90 and 140 patients, conducted at Cedars using technology from Samsung, Bayer, and AppliedVR.
“We just completed a randomized control trial that shows you can decrease pain with VR by 52 percent,” Samsung Chief Medical Officer Dr. David Rhew told MobiHealthNews in an interview at HIMSS last week. “And we’re now doing another study with Travelers to look specifically at how does that apply specifically in a worker’s compensation environment? How does that impact cost or return to work?”
Patients in the trial will use therapeutic VR — delivered via a Samsung Gear VR headset paired with a TENS nerve stimulation device from Bayer and a GearFit 2 tracker, also from Samsung. Participants will track day-to-day functional status, work productivity, and their use of pain medications.
To read the full article.